NCT00694707 - Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia | Biotech Hunter

Enrollment

732

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Schizophrenia

Interventions

DRUG

Placebo

Placebo was supplied in capsules.

DRUG

Cariprazine

Cariprazine was supplied in capsules

DRUG

Risperidone

Risperidone was supplied in capsules

Trial Locations (65)

14000

Forest Investigative Site, Chernihiv

15586

Forest Investigative Site, Kota Bharu

20016

Forest Investigative Site, Washington D.C.

21202

Forest Investigative Site, Baltimore

28117

Forest Investigative Site, Memphis

29405

Forest Investigative Site, Charleston

30990

Forest Investigative Site, Ipoh

31250

Forest Investigative Site, Ulu Kinta

34208

Forest Investigative Site, Bradenton

34741

Forest Investigative Site, Kissimmee

39232

Forest Investigative Site, Flowood

45219

Forest Investigative Site, Cincinnati

46020

Forest Investigative Site, Ternopil

49616

Forest Investigative Site, Dnipropetrovsk

59100

Forest Investigative Site, Lembah Pantai

61068

Forest Investigative Site, Kharkiv

63044

Forest Investigative Site, Bridgeton

65006

Forest Investigative Site, Odesa

70601

Forest Investigative Site, Lake Charles

73488

Forest Investigative Site, Kherson, Vil. Stepanivka

75062

Forest Investigative Site, Irving

77008

Forest Investigative Site, Houston

77021

Forest Investigative Site, Houston

80100

Forest Investigative Site, Johor Bahru

83037

Forest Investigative Site, Donetsk

90723

Forest Investigative Site, Paramount

90813

Forest Investigative Site, Long Beach

92056

Forest Investigative Site, Oceanside

92506

Forest Investigative Site, Riverside

92626

Forest Investigative Site, Costa Mesa

115522

Forest Investigative Site 1, Moscow

Forest Investigative Site 2, Moscow

117152

Forest Investigative Site, Moscow

163060

Forest Investigative Site, Arkhangelsk